Clinical Trials Browser

Phase 1/2 × Radiation Injuries × Androgen Antagonists × Clear all

NCT05003752 2023-03-07

Hypo-Combi

Phase 1/2 Active not recruiting

Prostatic Neoplasms, Radiation Injuries